For help on how to get the results you want, see our search tips.
9841 results
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel ratiopharm GmbH (updated)
clopidogrel, Peripheral Vascular Diseases, Acute Coronary Syndrome, Myocardial Infarction, Stroke
Date of authorisation: 28/07/2009,
, Revision: 12, Withdrawn, Last updated: 25/01/2021
-
List item
Human medicine European public assessment report (EPAR): Ofev (updated)
nintedanib, Idiopathic Pulmonary Fibrosis
Date of authorisation: 14/01/2015,
, Revision: 17, Authorised, Last updated: 25/01/2021
-
List item
Veterinary medicine European public assessment report (EPAR): Velactis (updated)
cabergoline,
Date of authorisation: 09/12/2015, Revision: 1, Withdrawn, Last updated: 25/01/2021 -
List item
Human medicine European public assessment report (EPAR): Kovaltry (updated)
octocog alfa, Hemophilia A
Date of authorisation: 18/02/2016, Revision: 10, Authorised, Last updated: 25/01/2021 -
List item
Veterinary medicine European public assessment report (EPAR): Profender (updated)
emodepside, praziquantel, Dogs, Cats
Date of authorisation: 27/07/2005, Revision: 19, Authorised, Last updated: 25/01/2021 -
List item
Human medicine European public assessment report (EPAR): Ocrevus (updated)
ocrelizumab, Multiple Sclerosis
Date of authorisation: 08/01/2018,
, Revision: 9, Authorised, Last updated: 22/01/2021
-
List item
Human medicine European public assessment report (EPAR): Zerbaxa (updated)
ceftolozane sulfate, tazobactam sodium, Bacterial Infections
Date of authorisation: 18/09/2015, Revision: 13, Authorised, Last updated: 22/01/2021 -
List item
Human medicine European public assessment report (EPAR): Symkevi (updated)
tezacaftor, ivacaftor, Cystic Fibrosis
Date of authorisation: 31/10/2018,, 
, Revision: 7, Authorised, Last updated: 22/01/2021
-
List item
Human medicine European public assessment report (EPAR): Dupixent (updated)
dupilumab, Dermatitis, Atopic
Date of authorisation: 27/09/2017,, Revision: 9, Authorised, Last updated: 22/01/2021
-
List item
Human medicine European public assessment report (EPAR): Blincyto (updated)
blinatumomab, Precursor Cell Lymphoblastic Leukemia-Lymphoma
Date of authorisation: 23/11/2015,, , Revision: 11, Authorised, Last updated: 22/01/2021
-
List item
Human medicine European public assessment report (EPAR): Kalydeco (updated)
ivacaftor, Cystic Fibrosis
Date of authorisation: 23/07/2012,, , Revision: 27, Authorised, Last updated: 22/01/2021
-
List item
Human medicine European public assessment report (EPAR): ViraferonPeg (updated)
peginterferon alfa-2b, Hepatitis C, Chronic
Date of authorisation: 28/05/2000, Revision: 36, Withdrawn, Last updated: 22/01/2021 -
List item
Human medicine European public assessment report (EPAR): Tafinlar (updated)
dabrafenib mesylate, Melanoma
Date of authorisation: 26/08/2013, Revision: 22, Authorised, Last updated: 22/01/2021 -
List item
Human medicine European public assessment report (EPAR): Tremfya (updated)
guselkumab, Psoriasis
Date of authorisation: 10/11/2017,, Revision: 5, Authorised, Last updated: 22/01/2021
-
List item
Human medicine European public assessment report (EPAR): Tasigna (updated)
nilotinib, Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Date of authorisation: 19/11/2007, Revision: 38, Authorised, Last updated: 22/01/2021 -
List item
Human medicine European public assessment report (EPAR): Ervebo (updated)
recombinant vesicular stomatitis virus (strain indiana) with a deletion of the envelope glycoprotein, replaced with the zaire ebolavirus (strain kikwit 1995) surface glycoprotein, Hemorrhagic Fever, Ebola
Date of authorisation: 11/11/2019,, Revision: 2, Authorised, Last updated: 22/01/2021
-
List item
Human medicine European public assessment report (EPAR): Wakix (updated)
pitolisant, Narcolepsy
Date of authorisation: 31/03/2016,, , Revision: 9, Authorised, Last updated: 21/01/2021
-
List item
Human medicine European public assessment report (EPAR): Zebinix (updated)
eslicarbazepine acetate, Epilepsy
Date of authorisation: 21/04/2009, Revision: 27, Authorised, Last updated: 21/01/2021 -
List item
Human medicine European public assessment report (EPAR): Mysimba (updated)
bupropion hydrochloride, naltrexone hydrochloride, Obesity, Overweight
Date of authorisation: 26/03/2015,, Revision: 18, Authorised, Last updated: 21/01/2021
-
List item
Human medicine European public assessment report (EPAR): Oncaspar (updated)
pegaspargase, Precursor Cell Lymphoblastic Leukemia-Lymphoma
Date of authorisation: 14/01/2016,, Revision: 12, Authorised, Last updated: 21/01/2021
-
List item
Human medicine European public assessment report (EPAR): Odefsey (updated)
emtricitabine, rilpivirine hydrochloride, tenofovir alafenamide, HIV Infections
Date of authorisation: 21/06/2016, Revision: 17, Authorised, Last updated: 21/01/2021 -
List item
Human medicine European public assessment report (EPAR): Oslif Breezhaler (updated)
indacaterol maleate, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 29/11/2009, Revision: 16, Authorised, Last updated: 20/01/2021 -
List item
Veterinary medicine European public assessment report (EPAR): Bravecto (updated)
fluralaner, Dogs, Cats
Date of authorisation: 11/02/2014, Revision: 13, Authorised, Last updated: 19/01/2021 -
List item
Human medicine European public assessment report (EPAR): Recarbrio (updated)
imipenem monohydrate, cilastatin sodium, relebactam monohydrate, Gram-Negative Bacterial Infections
Date of authorisation: 13/02/2020,, Revision: 1, Authorised, Last updated: 19/01/2021
-
List item
Human medicine European public assessment report (EPAR): Ryzodeg (updated)
insulin aspart, insulin degludec, Diabetes Mellitus
Date of authorisation: 21/01/2013, Revision: 12, Authorised, Last updated: 19/01/2021